The Pretreatment Albumin to Globulin Ratio Has Predictive Value for Long-Term Mortality in Nasopharyngeal Carcinoma.

Xiao-Jing Du,Ling-Long Tang,Yan-Ping Mao,Ying Sun,Mu-Sheng Zeng,Tie-Bang Kang,Wei-Hua Jia,Ai-Hua Lin,Jun Ma

DOI: https://doi.org/10.1371/journal.pone.0094473

IF: 3.7

2014-01-01

PLoS ONE

Abstract:BACKGROUND:Low serum albumin is predictive of poor survival in nasopharyngeal carcinoma (NPC). We evaluated the ability of the pretreatment albumin/globulin ratio (AGR) to predict long-term mortality in patients with NPC.METHODS:This retrospective study examined an unselected cohort of 694 patients with NPC who had documented pretreatment total serum protein and serum albumin levels (ALB). AGR was calculated as [AGR = ALB/(total serum protein--ALB)]. Survival analysis was used to evaluate the predictive value of AGR.RESULTS:Multivariate analysis demonstrated that a low pretreatment serum AGR (<1.4) was an independent predictor of poor OS (P  = 0.029) and DMFS (P  = 0.033). A low AGR was significantly associated with advanced stage disease (P<0.001), high white blood cell count (P  = 0.033), high neutrophil count (P  = 0.047), high total serum protein (P<0.001) and low ALB (P<0.001).CONCLUSION:The pretreatment AGR may represent a simple, potentially useful predictive biomarker for evaluating the long-term prognosis of patients with undifferentiated NPC.